Items where Author is "Payton, A"
Up a level |
Group by: Item Type | No Grouping
Number of items: 2.
Zhou, D ORCID: https://orcid.org/0000-0001-9061-1224, King, EH, Rothwell, S, Krystufkova, O, Notarnicola, A, Coss, S, Abdul-Aziz, R, Miller, KE, Dang, A, Yu, GR, Drew, J, Lundström, E, Pachman, LM, Mamyrova, G, Curiel, RV, De Paepe, B, De Bleecker, JL, Payton, A, Ollier, W ORCID: https://orcid.org/0000-0001-6502-6584, O'Hanlon, TP, Targoff, IN, Flegel, WA, Sivaraman, V, Oberle, E, Akoghlanian, S, Driest, K, Spencer, CH, Wu, YL, Nagaraja, HN, Ardoin, SP, Chinoy, H ORCID: https://orcid.org/0000-0001-6492-1288, Rider, LG, Miller, FW ORCID: https://orcid.org/0000-0003-2831-9593, Lundberg, IE ORCID: https://orcid.org/0000-0002-6068-9212, Padyukov, L ORCID: https://orcid.org/0000-0003-2950-5670, Vencovský, J, Lamb, JA ORCID: https://orcid.org/0000-0002-7248-0539 and Yu, CY ORCID: https://orcid.org/0000-0002-5218-7503
(2023)
Low copy numbers of complement C4 and C4A deficiency are risk factors for myositis, its subgroups and autoantibodies.
Annals of the Rheumatic Diseases, 82 (2).
pp. 235-245.
ISSN 0003-4967
Lam, M ORCID: https://orcid.org/0000-0002-4256-7844, Chen, CY, Ge, T, Xia, Y, Hill, DW, Trampush, JW, Yu, J, Knowles, E, Davies, G ORCID: https://orcid.org/0000-0003-1120-7026, Stahl, EA, Huckins, L, Liewald, DC ORCID: https://orcid.org/0000-0002-0544-7368, Djurovic, S, Melle, I ORCID: https://orcid.org/0000-0002-9783-548X, Christoforou, A, Reinvang, I, DeRosse, P ORCID: https://orcid.org/0000-0003-0823-8163, Lundervold, AJ ORCID: https://orcid.org/0000-0002-6819-6164, Steen, VM, Espeseth, T, Räikkönen, K, Widen, E, Palotie, A, Eriksson, JG, Giegling, I, Konte, B ORCID: https://orcid.org/0000-0001-5287-308X, Hartmann, AM, Roussos, P ORCID: https://orcid.org/0000-0002-4640-6239, Giakoumaki, S, Burdick, KE, Payton, A, Ollier, W ORCID: https://orcid.org/0000-0001-6502-6584, Chiba-Falek, O ORCID: https://orcid.org/0000-0002-2529-8785, Koltai, DC, Need, AC, Cirulli, ET, Voineskos, AN ORCID: https://orcid.org/0000-0003-0156-0395, Stefanis, NC, Avramopoulos, D ORCID: https://orcid.org/0000-0003-1492-9104, Hatzimanolis, A, Smyrnis, N, Bilder, RM ORCID: https://orcid.org/0000-0001-5085-7852, Freimer, NB, Cannon, TD, London, E ORCID: https://orcid.org/0000-0003-3577-7808, Poldrack, RA ORCID: https://orcid.org/0000-0001-6755-0259, Sabb, FW, Congdon, E, Conley, ED, Scult, MA, Dickinson, D, Straub, RE, Donohoe, G, Morris, D ORCID: https://orcid.org/0000-0002-3413-570X, Corvin, A, Gill, M ORCID: https://orcid.org/0000-0003-0206-5337, Hariri, AR, Weinberger, DR ORCID: https://orcid.org/0000-0003-2409-2969, Pendleton, N, Bitsios, P, Rujescu, D, Lahti, J ORCID: https://orcid.org/0000-0002-4310-5297, Le Hellard, S, Keller, MC, Andreassen, OA ORCID: https://orcid.org/0000-0002-4461-3568, Deary, IJ ORCID: https://orcid.org/0000-0002-1733-263X, Glahn, DC, Huang, H, Liu, C ORCID: https://orcid.org/0000-0002-5986-4415, Malhotra, AK and Lencz, T ORCID: https://orcid.org/0000-0001-8586-338X
(2021)
Identifying nootropic drug targets via large-scale cognitive GWAS and transcriptomics.
Neuropsychopharmacology, 46 (10).
pp. 1788-1801.
ISSN 0893-133X